PTC Therapeutics, Inc.
PTCT
$48.13
-$0.06-0.13%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -363.30M | -453.20M | -479.52M | -579.22M | -626.60M |
| Total Depreciation and Amortization | 75.66M | 149.60M | 205.17M | 249.16M | 236.59M |
| Total Amortization of Deferred Charges | 1.20M | 1.19M | 1.46M | 1.73M | 1.87M |
| Total Other Non-Cash Items | 78.00M | 142.88M | 178.15M | 247.37M | 233.73M |
| Change in Net Operating Assets | 100.74M | -18.45M | -20.77M | 22.79M | -4.00M |
| Cash from Operations | -107.69M | -177.97M | -115.50M | -58.17M | -158.42M |
| Capital Expenditure | -6.50M | -8.30M | -14.14M | -27.76M | -28.44M |
| Sale of Property, Plant, and Equipment | 28.06M | 28.06M | 28.04M | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 22.63M | -337.70M | -318.77M | -234.94M | -148.30M |
| Cash from Investing | 44.18M | -317.95M | -304.87M | -262.70M | -176.74M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -1.49M | -301.49M | -301.49M | -301.49M | -301.38M |
| Issuance of Common Stock | 33.76M | 9.71M | 12.58M | 26.37M | 29.99M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 223.59M | 1.14B | 1.16B | 917.97M | 917.79M |
| Cash from Financing | 255.87M | 849.88M | 870.87M | 642.85M | 646.40M |
| Foreign Exchange rate Adjustments | -7.33M | 4.42M | -6.45M | 9.05M | 3.11M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 185.03M | 358.38M | 444.05M | 331.03M | 314.36M |